These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 14751577

  • 1. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA, Clowes JA, Eagleton AC, Al Hadari A, Eastell R, Blumsohn A.
    Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
    [Abstract] [Full Text] [Related]

  • 2. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM.
    Anticancer Res; 2003 Jan; 23(2A):1027-9. PubMed ID: 12820342
    [Abstract] [Full Text] [Related]

  • 3. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK.
    Clin Lab; 2006 Jan; 52(9-10):499-509. PubMed ID: 17078477
    [Abstract] [Full Text] [Related]

  • 4. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
    Janckila AJ, Takahashi K, Sun SZ, Yam LT.
    Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
    [Abstract] [Full Text] [Related]

  • 5. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
    Nenonen A, Cheng S, Ivaska KK, Alatalo SL, Lehtimäki T, Schmidt-Gayk H, Uusi-Rasi K, Heinonen A, Kannus P, Sievänen H, Vuori I, Väänänen HK, Halleen JM.
    J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
    [Abstract] [Full Text] [Related]

  • 6. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R, Seppänen J, Laitinen K, Katajamäki A, Risteli J, Välimäki MJ.
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [Abstract] [Full Text] [Related]

  • 7. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
    Ylipahkala H, Fagerlund KM, Janckila AJ, Houston B, Laurie D, Halleen JM.
    Clin Lab; 2009 Sep; 55(5-6):223-8. PubMed ID: 19728556
    [Abstract] [Full Text] [Related]

  • 8. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z, Konieczna M, Saracyn M, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
    [Abstract] [Full Text] [Related]

  • 9. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP, Suominen MI, Peng Z, Halleen JM.
    Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
    [Abstract] [Full Text] [Related]

  • 10. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ, Neustadt DH, Nakasato YR, Halleen JM, Hentunen T, Yam LT.
    Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
    [Abstract] [Full Text] [Related]

  • 11. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Väänänen HK.
    Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
    [Abstract] [Full Text] [Related]

  • 12. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
    Uchida K, Nakanishi M, Yoh K.
    Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
    [Abstract] [Full Text] [Related]

  • 13. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
    Wu ZQ, Zhang Y, Xie E, Song WJ, Yang RX, Yan CJ, Zhang BF, Xu HG.
    PLoS One; 2016 Jan; 11(1):e0147554. PubMed ID: 26800211
    [Abstract] [Full Text] [Related]

  • 14. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
    Ohashi T, Igarashi Y, Mochizuki Y, Miura T, Inaba N, Katayama K, Tomonaga T, Nomura F.
    Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
    Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM.
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
    [Abstract] [Full Text] [Related]

  • 16. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.
    Ylipahkala H, Halleen JM, Kaija H, Vihko P, Väänänen HK.
    Biochem Biophys Res Commun; 2003 Aug 22; 308(2):320-4. PubMed ID: 12901871
    [Abstract] [Full Text] [Related]

  • 17. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 18. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
    Janckila AJ, Simons RM, Yam LT.
    Clin Chim Acta; 2004 Sep 01; 347(1-2):157-67. PubMed ID: 15313154
    [Abstract] [Full Text] [Related]

  • 19. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
    Chao TY, Lee SH, Chen MM, Neustadt DH, Chaudhry UA, Yam LT, Janckila AJ.
    Clin Chim Acta; 2005 Sep 01; 359(1-2):132-40. PubMed ID: 15993395
    [Abstract] [Full Text] [Related]

  • 20. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Sep 01; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.